Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease

Journal of the American College of Cardiology

Volumn 68, Issue 10, 2016, Pages 999-1009

  Cavalcante, Rafael ^a,b   Sotomi, Yohei ^c   Lee, Cheol W ^d   Ahn, Jung Min ^d   Farooq, Vasim ^e   Tateishi, Hiroki ^a   Tenekecioglu, Erhan ^a   Zeng, Yaping ^a   Suwannasom, Pannipa ^c   Collet, Carlos ^c   Albuquerque, Felipe N ^a   Onuma, Yoshinobu ^a   Park, Seung Jung ^d   Serruys, Patrick W ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d University of Ulsan College of Medicine   (South Korea)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

coronary artery bypass graft surgery; left main coronary artery disease; long term outcomes; percutaneous coronary intervention; randomized controlled trials

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; CALIBRATION; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNPROTECTED LEFT MAIN CORONARY DISEASE; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84993949415     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.06.024     Document Type: Article

References (21)

1. 1 Park, S.J., Ahn, J.M., Kim, Y.H., et al. Temporal trends in revascularization strategy and outcomes in left main coronary artery stenosis: data from the ASAN Medical Center-Left MAIN Revascularization registry. Circ Cardiovasc Interv, 8, 2015, e001846.
2. 2 Park, S.J., Kim, Y.H., Park, D.W., et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364 (2011), 1718–1727.
3. 3 Serruys, P.W., Morice, M.C., Kappetein, A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009), 961–972.
4. 4 Morice, M.C., Serruys, P.W., Kappetein, A.P., et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121 (2010), 2645–2653.
5. 5 Windecker, S., Kolh, P., Alfonso, F., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35 (2014), 2541–2619.
6. 6 Ferrante, G., Presbitero, P., Valgimigli, M., et al. Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials. EuroIntervention 7 (2011), 738–746 1.
7. 7 Jang, J.S., Choi, K.N., Jin, H.Y., et al. Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease. Am J Cardiol 110 (2012), 1411–1418.
8. 8 Gargiulo, G., Tamburino, C., Capodanno, D., Five-year outcomes of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with left main coronary artery disease: An updated meta-analysis of randomized trials and adjusted observational studies. Int J Cardiol 195 (2015), 79–81.
9. 9 Morice, M.C., Serruys, P.W., Kappetein, A.P., et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 129 (2014), 2388–2394.
10. 10 Ahn, J.M., Roh, J.H., Kim, Y.H., et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J Am Coll Cardiol 65 (2015), 2198–2206.
11. 11 Farooq, V., van Klaveren, D., Steyerberg, E.W., et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381 (2013), 639–650.
12. 12 Campos, C.M., van Klaveren, D., Iqbal, J., et al. Predictive performance of SYNTAX Score II in patients with left main and multivessel coronary artery disease-analysis of CREDO-Kyoto registry. Circ J 78 (2014), 1942–1949.
13. 13 Park, D.W., Seung, K.B., Kim, Y.H., et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 56 (2010), 117–124.
14. 14 Chieffo, A., Meliga, E., Latib, A., et al. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. J Am Coll Cardiol Intv 5 (2012), 718–727.
15. 15 Chieffo, A., Magni, V., Latib, A., et al. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. J Am Coll Cardiol Intv 3 (2010), 595–601.
16. 16 Kim, Y.H., Park, D.W., Ahn, J.M., et al. Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study. J Am Coll Cardiol Intv 5 (2012), 708–717.
17. 17 Shiomi, H., Morimoto, T., Furukawa, Y., et al. Comparison of percutaneous coronary intervention with coronary artery bypass grafting in unprotected left main coronary artery disease - 5-Year outcome from CREDO-Kyoto PCI/CABG registry cohort-2 -. Circ J 79 (2015), 1282–1289.
18. 18 Levine, G.N., Bates, E.R., Blankenship, J.C., et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58 (2011), e44–e122.
19. 19 Campos, C.M., Stanetic, B.M., Farooq, V., et al. Risk stratification in 3-vessel coronary artery disease: applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. Catheter Cardiovasc Interv 86 (2015), E229–E238.
20. 20 Campos, C.M., Christiansen, E.H., Stone, G.W., Serruys, P.W., The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation. EuroIntervention 11:Suppl V (2015), V115–V119.
21. 21 Campos, C.M., van Klaveren, D., Farooq, V., et al. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX score II. Eur Heart J 36 (2015), 1231–1241.